ID: ALA61661

Max Phase: Preclinical

Molecular Formula: C10H13NO3

Molecular Weight: 195.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCNC(=O)c1ccc(O)c(O)c1

Standard InChI:  InChI=1S/C10H13NO3/c1-2-5-11-10(14)7-3-4-8(12)9(13)6-7/h3-4,6,12-13H,2,5H2,1H3,(H,11,14)

Standard InChI Key:  VRUHXBUSPFHDDB-UHFFFAOYSA-N

Associated Targets(non-human)

COMT Catechol O-methyltransferase (43 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 195.22Molecular Weight (Monoisotopic): 195.0895AlogP: 1.24#Rotatable Bonds: 3
Polar Surface Area: 69.56Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.45CX Basic pKa: CX LogP: 1.32CX LogD: 1.28
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.64Np Likeness Score: -0.44

References

1. Brevitt SE, Tan EW..  (1997)  Synthesis and in vitro evaluation of two progressive series of bifunctional polyhydroxybenzamide catechol-O-methyltransferase inhibitors.,  40  (13): [PMID:9207944] [10.1021/jm9605187]

Source